Lyell completes LYL273 manufacturing transfer, pushes back Phase 1/2 data timelineSep 10Clinical readoutLyell Immunopharma, Inc.
BMS posts PRIME-HCC results; adds SOTYKTU label update, Phase 3 lung trialJul 2Weekly roundup, 7 itemsBristol Myers Squibbcisplatin
Sign inSign in